Skip to main content

Anna Wade

Analyst

Commercial Lead

Equibles does not estimate personal net worth.

About Anna Wade

Anna Wade is recorded as Analyst at Commercial Lead. Anna Wade has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for BridgeBio Pharma, Inc. on June 9, 2026. The companies whose calls Anna Wade spoke on are classified in the Healthcare sector.

Anna Wade on recent calls

“So, as Tom mentioned, we estimate there are around 2,000 patients in the U.S. with limb girdle musculotistry type 2I. Currently, we have around just over 500 genetically confirmed patients that we currently are tracking, and then we currently have ongoing efforts on patient finding, so that is leveraging the data and…”
Goldman Sachs 47th Annual Global Healthcare Conference ·
“So yeah we're really excited we have our commercial and sales leadership on board and we're getting ready to have the sale for us hired later this year. We also now have our medical leadership in place as well as a seasoned MSL team with neuromuscular and rare disease experience.”
BridgeBio Pharma, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Commercial Lead

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity